X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (163) 163
female (114) 114
index medicus (110) 110
oncology (98) 98
middle aged (93) 93
aged (88) 88
male (87) 87
adult (65) 65
chemotherapy (53) 53
cancer (47) 47
treatment outcome (46) 46
antineoplastic combined chemotherapy protocols - therapeutic use (45) 45
disease-free survival (38) 38
prognosis (36) 36
aged, 80 and over (33) 33
survival (29) 29
clinical trials (28) 28
care and treatment (26) 26
neoplasm staging (24) 24
analysis (23) 23
hematology, oncology and palliative medicine (23) 23
italy (23) 23
prospective studies (23) 23
medicine, general & internal (21) 21
therapy (21) 21
lung neoplasms - drug therapy (20) 20
research (20) 20
surgery (20) 20
trial (20) 20
follow-up studies (19) 19
ophthalmology (19) 19
survival rate (19) 19
randomized controlled trials as topic (18) 18
survival analysis (18) 18
breast cancer (17) 17
carcinoma, non-small-cell lung - drug therapy (17) 17
retrospective studies (17) 17
tumors (17) 17
chemotherapy, adjuvant (16) 16
kaplan-meier estimate (16) 16
risk factors (16) 16
abridged index medicus (15) 15
proportional hazards models (15) 15
antineoplastic combined chemotherapy protocols - adverse effects (14) 14
colorectal cancer (14) 14
double-blind method (14) 14
drug administration schedule (14) 14
medical research (14) 14
patients (14) 14
antineoplastic agents - therapeutic use (13) 13
glaucoma (13) 13
metastasis (13) 13
ovarian cancer (13) 13
reproducibility of results (13) 13
cancer therapies (12) 12
diagnosis (12) 12
health aspects (12) 12
lung neoplasms - mortality (12) 12
lung neoplasms - pathology (12) 12
medicine (12) 12
metaanalysis (12) 12
carcinoma (11) 11
combined modality therapy (11) 11
drug therapy (11) 11
fluorouracil - administration & dosage (11) 11
multivariate analysis (11) 11
mutation (11) 11
open-label (11) 11
ovarian neoplasms - drug therapy (11) 11
research design (11) 11
1st-line treatment (10) 10
adolescent (10) 10
antineoplastic combined chemotherapy protocols - administration & dosage (10) 10
carcinoma, non-small-cell lung - mortality (10) 10
cisplatin - administration & dosage (10) 10
colorectal neoplasms - drug therapy (10) 10
disease progression (10) 10
docetaxel (10) 10
efficacy (10) 10
multicenter (10) 10
paclitaxel (10) 10
antibodies, monoclonal, humanized (9) 9
bevacizumab (9) 9
biomarkers (9) 9
carboplatin - administration & dosage (9) 9
carcinoma, non-small-cell lung - pathology (9) 9
combination (9) 9
hypertension (9) 9
internal medicine (9) 9
lung cancer (9) 9
open-angle glaucoma (9) 9
population (9) 9
research article (9) 9
risk-factors (9) 9
sulfonamides - therapeutic use (9) 9
thiophenes - therapeutic use (9) 9
young adult (9) 9
adenocarcinoma (8) 8
adjuvant treatment (8) 8
breast neoplasms - drug therapy (8) 8
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Oncology, The, ISSN 1470-2045, 2014, Volume 15, Issue 7, pp. 713 - 721
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 6, pp. 738 - 746
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 10, pp. 981 - 988
Journal Article
Ricerca e Pratica, ISSN 1120-379X, 01/2017, Volume 33, Issue 1, pp. 37 - 40
Journal Article
Journal Article
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 06/2019, Volume 111, Issue 11, pp. 1232 - 1233
Journal Article
Journal of the National Cancer Institute, ISSN 0027-8874, 12/2008, Volume 100, Issue 23, pp. 1707 - 1716
Background Pelvic lymph nodes are the most common site of extrauterine tumor spread in early-stage endometrial cancer, but the clinical impact of... 
SURVIVAL | SURGERY | ONCOLOGY | RESECTION | ADENOCARCINOMA | POSTOPERATIVE RADIOTHERAPY | CORPUS CANCER | PATTERNS | OUTCOMES | BRACHYTHERAPY | Endometrial Neoplasms - radiotherapy | Lymph Node Excision | Predictive Value of Tests | Prognosis | Prospective Studies | Endometrial Neoplasms - mortality | Adenocarcinoma, Clear Cell - mortality | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Cystadenocarcinoma, Serous - pathology | Patient Selection | Carcinoma, Squamous Cell - mortality | Female | Chemotherapy, Adjuvant | Radiotherapy, Adjuvant | Adenocarcinoma, Papillary - pathology | Mixed Tumor, Mullerian - mortality | Kaplan-Meier Estimate | Proportional Hazards Models | Ovariectomy - methods | Adenocarcinoma, Papillary - mortality | Hysterectomy | Mixed Tumor, Mullerian - pathology | Disease-Free Survival | Carcinoma, Endometrioid - mortality | Endometrial Neoplasms - surgery | Cystadenocarcinoma, Serous - mortality | Endometrial Neoplasms - drug therapy | Endometrial Neoplasms - pathology | Adenocarcinoma, Clear Cell - pathology | Aged | Neoplasm Staging | Research Design | Carcinoma, Endometrioid - pathology | Care and treatment | Endometrial cancer | Patient outcomes | Surgery | Development and progression | Diagnosis | Health aspects | Lymph nodes | Comparative studies | Lymphatic system | Medical prognosis | Gynecology
Journal Article